Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001140361-25-004893·Blue Owl Capital Holdings LP
Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 21077P108
Event date: 2024-12-31
- Filing-level shares
- 6,357,928
- Percent of class
- 8.48%
- Blue Owl Capital Holdings LP
Shares: 6,357,928 · Class: 8.48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-004893
- Form type
- SCHEDULE 13G/A
- Filer
- Blue Owl Capital Holdings LP
- CIK
- CIK 1858703
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership